Study Summary:
A Phase 3a, double-blind, placebo-controlled, randomized clinical trial assessing safety and efficacy of a botanical extract comprised of 22 traditional Chinese botanical agents for hot flushes and menopausal symptoms in postmenopausal women.
Qualified Participants Must:
• Be 40-65 years of age
•
Be menopausal and suffering from moderate to severe hot flashes
Qualified Participants May Receive:
Compensation for participation, all study related procedures (mammogram, pap smear, lab work) and study extract or placebo.